Pompe disease (glycogen storage disease type II) in Argentineans: Clinical manifestations and identification of 9 novel mutations

[1]  N. Chamoles,et al.  Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[2]  M. Kroos,et al.  A case of childhood Pompe disease demonstrating phenotypic variability of p.Asp645Asn , 2004, Neuromuscular Disorders.

[3]  R. Howell,et al.  Pompe disease in infants and children. , 2004, The Journal of pediatrics.

[4]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[5]  L. Y. Wang,et al.  Point mutation in Pompe disease in Chinese , 1994, Journal of Inherited Metabolic Disease.

[6]  S. Tsujino,et al.  New GAA mutations in Japanese patients with GSDII (Pompe disease). , 2003, Pediatric Neurology.

[7]  B. Bembi,et al.  Identification of four novel mutations in the alpha glucosidase gene in five Italian patients with infantile onset glycogen storage disease type II , 2003, American journal of medical genetics. Part A.

[8]  F. Martiniuk,et al.  Juvenile-onset glycogen storage disease type II with novel mutations in acid α-glucosidase gene , 2003, Neurology.

[9]  B. Byrne,et al.  Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). , 2002, Current molecular medicine.

[10]  F. Corsolini,et al.  Aberrant splicing at catalytic site as cause of infantile onset glycogen storage disease type II (GSDII): molecular identification of a novel IVS9 (+2GT-->GC) in combination with rare IVS10 (+1GT-->CT). , 2001, American journal of medical genetics.

[11]  I. Nonaka,et al.  Frequent mutations in Japanese patients with acid maltase deficiency , 2000, Neuromuscular Disorders.

[12]  P. Laforêt,et al.  Juvenile and adult-onset acid maltase deficiency in France , 2000, Neurology.

[13]  M. Ausems,et al.  Phenotypic expression of late-onset glycogen storage disease type II: identification of asymptomatic adults through family studies and review of reported families , 2000, Neuromuscular Disorders.

[14]  W. Hwu,et al.  Molecular genetic study of Pompe disease in Chinese patients in Taiwan , 1999, Human mutation.

[15]  L. Maquat,et al.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. , 1998, Trends in biochemical sciences.

[16]  C. Tifft,et al.  The African origin of the common mutation in African American patients with glycogen-storage disease type II. , 1998, American journal of human genetics.

[17]  M. Yacoub,et al.  The identification of five novel mutations in the lysosomal acid a‐(1,4) glucosidase gene from patients with glycogen storage disease type II , 1998 .

[18]  J. Smeitink,et al.  Glycogen storage disease type II: Genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry , 1998, Human mutation.

[19]  J. Shieh,et al.  Frequent mutation in Chinese patients with infantile type of GSD II in Taiwan: Evidence for a founder effect , 1998, Human mutation.

[20]  N. Raben,et al.  Glycogenosis type II: A juvenile‐specific mutation with an unusual splicing pattern and a shared mutation in African Americans , 1997, Human mutation.

[21]  N. Raben,et al.  A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II). , 1996, Human molecular genetics.

[22]  A. Reuser,et al.  Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. , 1995, Journal of Medical Genetics.

[23]  A. Reuser,et al.  Genotype‐phenotype correlation in adult‐onset acid maltase deficiency , 1995, Annals of neurology.

[24]  C. Boerkoel,et al.  Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. , 1995, American journal of human genetics.

[25]  S. Dimauro,et al.  Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation. , 1994, Human molecular genetics.

[26]  B. Oostra,et al.  The effect of a single base pair deletion (ΔT525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal α-glucosidase in patients with glycogen storage disease type II , 1994 .

[27]  A. Reuser,et al.  Deletion of exon 18 is a frequent mutation in glycogen storage disease type II. , 1994, Biochemical and biophysical research communications.

[28]  B. Oostra,et al.  The conservative substitution Asp-645-->Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II. , 1993, The Biochemical journal.

[29]  B. Oostra,et al.  Two mutations affecting the transport and maturation of lysosomal α‐glucosidase in an adult case of glycogen storage disease type II , 1993, Human mutation.

[30]  K. Hirschhorn,et al.  Identification of a missense mutation in an adult-onset patient with glycogenosis type II expressing only one allele. , 1991, DNA and cell biology.

[31]  S. Dimauro,et al.  Late-onset acid maltase deficiency: Biochemical studies of leukocytes , 1981, Journal of the Neurological Sciences.